APA (7th ed.) Citation

DS, H., TM, B., JJ, L., A, D., MS, B., AF, F., . . . RC, D. (2019). Larotrectinib in adult patients with solid tumours: A multi-centre, open-label, phase I dose-escalation study. Annals of oncology : official journal of the European Society for Medical Oncology, 30(2), 325. https://doi.org/10.1093/annonc/mdy539

Chicago Style (17th ed.) Citation

DS, Hong, et al. "Larotrectinib in Adult Patients with Solid Tumours: A Multi-centre, Open-label, Phase I Dose-escalation Study." Annals of Oncology : Official Journal of the European Society for Medical Oncology 30, no. 2 (2019): 325. https://doi.org/10.1093/annonc/mdy539.

MLA (9th ed.) Citation

DS, Hong, et al. "Larotrectinib in Adult Patients with Solid Tumours: A Multi-centre, Open-label, Phase I Dose-escalation Study." Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 30, no. 2, 2019, p. 325, https://doi.org/10.1093/annonc/mdy539.